在Ménière病中Goreisan的有效性
1Otolaryngology-Head and Neck Surgery, Osaka Metropolitan University, Osaka, JPN.
Cureus
|August 27, 2025
概括
康波的药物Goreisan在Ménière的患者中显著降低了的发生率
科学领域:
- 神经学
- 综合医学
- 药理学
背景情况:
- 梅尼尔病是一种慢性内耳疾病,其特征是头,耳和听力损失.
- 目前MD的治疗方法通常集中在症状管理上,疾病修改的选择有限.
研究的目的:
- 评估日本传统草药Goreisan在治疗梅内尔病症状方面的有效性.
- 评估Goreisan对MD患者头频率,头严重程度和听力功能的影响.
主要方法:
- 对164名梅尼尔病患者的回顾性分析 (2017年4月至2022年3月).
- 52名用Goreisan治疗的患者和31名没有接受尿剂治疗的患者之间的比较.
- 在12个月内评估头频率,头障碍清单 (DHI) 评分和听力功能.
主要成果:
- 在2,6个月和12个月后,Goreisan组表现出显著的头减轻.
- 这两组的DHI得分都有所改善,这表明贝塔希斯和生活方式的改变可能有所帮助.
- 在Goreisan组中没有观察到听力功能的显著变化.
结论:
- 戈瑞桑可能是一种安全有效的治疗方法,可降低梅尼尔病的头频率.
- 在MD患者中,Goreisan似乎没有改善听力功能.
- 需要进一步的安慰剂对照试验来验证Goreisan的疗效.
更多相关视频
10:27In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears
Published on: February 21, 2018
10.7K
09:26A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
Published on: March 23, 2016
19.7K
相关概念视频
Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717
Open Angle Glaucoma: Treatment
561
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
561
